TickerFactsScreenerDevelopers

TFA Therapeutics, Inc. (RAJAF) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$365.4K2022: -$321.4K2023: $359.7K2024: $312.0K2025: -$35.8K-$35.8K
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$35.8K-111.5%
2024$312.0K-13.3%
2023$359.7K+211.9%
2022-$321.4K+12.0%
2021-$365.4K—